Table S5.
Papillary thyroid carcinoma
| References | Country | Ethnicity | Histology | Control
|
PTC
|
Methods | |||
|---|---|---|---|---|---|---|---|---|---|
| U (n) | M (n) | U (n) | M (n) | ||||||
| Qu and Xue3 | People’s Republic of China | Asian | Thyroid carcinoma | 21 | 7 | 13 | 15 | MSP | |
| Wang et al6 | People’s Republic of China | Asian | Thyroid carcinoma | 10 | 0 | 19 | 42 | MSP | |
| Nakamura et al8 | USA | Caucasian | Thyroid carcinoma | 27 | 0 | 23 | 11 | MSP | |
| Xing et al9 | USA | Caucasian | Thyroid carcinoma | 14 | 0 | 24 | 6 | QMSP | |
| Schagdarsurengin et al10 | Germany | Caucasian | Thyroid carcinoma | 3 | 1 | 5 | 8 | MSP | |
Abbreviations: M, methylation sample; MSP, methylation-specific PCR; PCR, polymerase chain reaction; PTC, papillary thyroid cancer; QMSP, quantitative methylation-specific PCR; U, unmethylation sample.